BHVN Q2 2018 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$38M

Net Income

-$39M

EPS (Diluted)

$-1.01

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$239M

Total Liabilities

$120M

Stockholders' Equity

$119M

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$38M	-$25M	-51.1%
Net Income	-$39M	-$38M	-2.2%